Miro, Elizabeth .
HRN: 09-06-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2024
CEFOTAXIME 500MG (VIAL)
07/10/2024
07/16/2024
PO
500mg
BId
Thinly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes